Search research articles
Contact Us
Filters
Showing results (71-80 of 999) with videos related to
Page
of 100
Sort By:
Current Atherosclerosis Reports
|
December 16, 2006
Squalene synthase inhibition: a novel target for the management of dyslipidemia
Michael H Davidson
Current Atherosclerosis Reports
|
December 10, 2003
Biologic therapies for dyslipidemia
Michael H Davidson
The American Journal of Cardiology
|
June 5, 2004
Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome
Michael H Davidson
Perspectives in Biology and Medicine
|
January 12, 2016
Genomics, "Discovery Science," Systems Biology, and Causal Explanation: What Really Works?
Eric H Davidson
Expert Opinion on Drug Safety
|
December 24, 2005
Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions
Michael H Davidson
Current Cardiology Reports
|
October 16, 2003
Newer pharmaceutical agents to treat lipid disorders
Michael H Davidson
Cleveland Clinic Journal of Medicine
|
July 24, 2008
Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications
Michael H Davidson
Current Cardiology Reports
|
October 28, 2008
METEOR and ENHANCE: a tale of two CIMT trials: part 1
Michael H Davidson
Current Cardiology Reports
|
October 28, 2008
METEOR and ENHANCE: a tale of two CIMT trials: part 2
Michael H Davidson
The American Journal of Cardiology
|
December 7, 2002
Combination therapy for dyslipidemia: safety and regulatory considerations
Michael H Davidson
Page
of 100
Search research articles
Search
Showing results (71-80 of 999) with videos related to
Sort By:
Page
of 100
Current Atherosclerosis Reports
|
December 16, 2006
Squalene synthase inhibition: a novel target for the management of dyslipidemia
Michael H Davidson
Current Atherosclerosis Reports
|
December 10, 2003
Biologic therapies for dyslipidemia
Michael H Davidson
The American Journal of Cardiology
|
June 5, 2004
Emerging therapeutic strategies for the management of dyslipidemia in patients with the metabolic syndrome
Michael H Davidson
Perspectives in Biology and Medicine
|
January 12, 2016
Genomics, "Discovery Science," Systems Biology, and Causal Explanation: What Really Works?
Eric H Davidson
Expert Opinion on Drug Safety
|
December 24, 2005
Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions
Michael H Davidson
Current Cardiology Reports
|
October 16, 2003
Newer pharmaceutical agents to treat lipid disorders
Michael H Davidson
Cleveland Clinic Journal of Medicine
|
July 24, 2008
Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications
Michael H Davidson
Current Cardiology Reports
|
October 28, 2008
METEOR and ENHANCE: a tale of two CIMT trials: part 1
Michael H Davidson
Current Cardiology Reports
|
October 28, 2008
METEOR and ENHANCE: a tale of two CIMT trials: part 2
Michael H Davidson
The American Journal of Cardiology
|
December 7, 2002
Combination therapy for dyslipidemia: safety and regulatory considerations
Michael H Davidson
Page
of 100